← Evidence map

ArticleNature communications2022

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.

Ezra Y Rosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

65 papers cite itlatest 60 shown

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35304457